within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A02B_DrugsForPepticUlcerAndGastroOesophagealRefluxDis.A02BD09_LansoprazoleClarithromyc;

model LansoprazoleClarithromyc
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.8,
    Cl = 6.11111111111111e-06,
    adminDuration = 600,
    adminMass = 1000 / 1000000,
    adminCount = 1,
    Vd = 0.036,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0025,
    Tlag = 600);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>LansoprazoleClarithromycinAndTinidazole</td></tr><tr><td>ATC code:</td><td>A02BD09</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>1000</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>36</td><td>L</td></tr>
    <tr><td>clearance:</td><td>22</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>This drug combination includes lansoprazole (a proton pump inhibitor), clarithromycin (a macrolide antibiotic), and tinidazole (a nitroimidazole antimicrobial). It is used primarily in the treatment of Helicobacter pylori infection associated with peptic ulcer disease. Lansoprazole suppresses gastric acid secretion, while clarithromycin and tinidazole act as antibiotics targeting the bacteria. The combination is approved in some countries as a therapy for H. pylori eradication.</p><h4>Pharmacokinetics</h4><p>No direct publication with full pharmacokinetic parameters for the fixed-dose combination of lansoprazole, clarithromycin, and tinidazole is available. The following parameters are estimated based on available pharmacokinetic data of each individual component in healthy adults (both sexes, mean age ~30 years) after oral administration.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.A.A02BD09 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end LansoprazoleClarithromyc;
